Wells Fargo
MDCO

Wells Fargo’s Medicines Co MDCO Stock Holding History

Wells Fargo’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-164,400
Closed -$79K – 6986
2019
Q3 		$79K Buy
164,400
+57,200
+53% +$2.28M ﹤0.01% 5416
2019
Q2 		$2K Buy
+107,200
New +$3.5M ﹤0.01% 6211

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wells Fargo's MDCO Position: Q1 2020 in Review

Wells Fargo sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,301,226 shares — an estimated $111M sold.

Wells Fargo first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $111M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Wells Fargo reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Wells Fargo sold 1,301,226 Medicines Co shares in Q1 2020, an estimated $111M.
  • Wells Fargo first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Wells Fargo's Medicines Co position peaked at $111M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.